UK SABR Consortium (@uksabr.bsky.social)
The SABR UK consortium’s official BlueSky account. Please follow us and share our BlueSky page! https://bsky.app/profile/uksabr.bsky.social
The SABR UK consortium’s official BlueSky account. Please follow us and share our BlueSky page! https://bsky.app/profile/uksabr.bsky.social
The MAXILUS study will evaluate the maximum approved dose of luspatercept in lower-risk myelodysplastic syndrome.
For adults ages 27 to 45, vaccinating against human papillomavirus (HPV) is costlier and less effective than vaccinating younger people to prevent HPV-related cancers (Ann…
Welcome! You are invited to join a webinar: SSO & ASTS Virtual Tumor Board: Transplant Oncology . After registering, you will receive a confirmation email…
Passionate Radiation Oncologist Chairman University Hospital Zurich Professor University of Zurich President of ESTRO
The SABR UK consortium’s official BlueSky account. Please follow us and share our BlueSky page! https://bsky.app/profile/uksabr.bsky.social
Abstract. Antibody–drug conjugates (ADC) represent one of the most rapidly expanding treatment modalities in oncology, with 11 ADCs approved by the FDA and more than…
Program for AACR Special Conference in Cancer Research: DNA Methylation, Clonal Hematopoiesis, and Cancer
This guidance provides recommendations to sponsors regarding measurement of ovarian toxicity using clinical measures and biomarkers of ovarian function
Community of people living with arthritis & rheumatic disease. EST 1999.